September 13, 2012 (Ioannina, Greece) — A new meta-analysis looking at the effects of omega-3 fatty acids in patients at high risk for cardiovascular events has shown that the supplements have no effect on hard clinical outcomes, including all-cause mortality, cardiac death, sudden death, MI, or stroke. There was a trend toward benefit in the prevention of sudden death, but the reduction failed to reach statistical significance, a finding the researchers believe refutes any supposed antiarrhythmic-mediated effect of omega-3 fatty acids.
"The meta-analysis, taking into account the recent and previously published trials, showed that omega-3 fatty acids did not significantly reduce the incidence of cardiovascular events," senior investigator Dr Moses Elisaf (University Hospital of Ioannina, Greece) told heartwire. "However, there was a trend toward benefit in terms of sudden death, about a 13% reduction, and myocardial infarction, about a 10% reduction, but the decrease was not statistically significant. So, we can conclude from this meta-analysis and other recently published trials that the effect of omega-3 fatty-acid supplementation in high-risk patients is rather low. They are without side effects, but without significant efficacy."
The study is published in the September 12, 2012 issue of the Journal of the American Medical Association
The report, Putting Pain on the Agenda, identifies four key priorities for action that will improve the quality of life of those who live with pain.
These include
- the development of clear national standards for clinical practise and education
- the need to raise public awareness of pain
- the development of comprehensive guidance for commissioners
- a national strategy to cope with the problem.
Healthcare professionals were joined by patients and parliamentarians at the launch of the report - the findings of which are based on the first ever English Pain Summit which took place in November 2011.
Physiotherapist Kate Jolly, who is studying an MSc in "pain, Science and Society" and is also involved in the all party parliamentary chronic pain group, welcomed the report’s recommendations.
‘Physiotherapists are ideally placed to embrace this report as our distinctive qualities of listening and taking time to understand patients enables us to give the necessary empowerment required to fulfill these goals,’ she said.
‘This is not exclusive to the field of musculoskeletal pain but spans our diverse skills in cancer pain, headaches, abdominal syndromes such as IBS and neurology, to name but a few.’

